Health Care & Life Sciences » Pharmaceuticals | Estechpharma Co. Ltd.

Estechpharma Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
11,470
22,194
10,858
20,530
21,468
Total Accounts Receivable
14,649
15,308
8,576
10,375
9,255
Inventories
22,504
25,723
16,438
14,680
14,017
Other Current Assets
1,146
764
968
347
1,544
Total Current Assets
49,769
63,990
36,840
45,932
46,284
Net Property, Plant & Equipment
46,370
43,992
42,998
38,338
35,443
Total Investments and Advances
4,682
2,393
5,489
7,018
10,435
Intangible Assets
3,200
4,157
6,002
5,832
4,351
Other Assets
348
23
34
353
338
Total Assets
105,576
116,008
93,014
99,216
99,172
ST Debt & Current Portion LT Debt
14,600
25,765
7,000
7,000
6,000
Accounts Payable
4,191
7,427
3,027
3,675
3,003
Income Tax Payable
236
1,696
53
587
-
Other Current Liabilities
1,807
1,522
2,042
1,586
1,968
Total Current Liabilities
20,834
36,410
12,121
12,848
10,972
Long-Term Debt
13,427
-
6,000
6,000
-
Provision for Risks & Charges
486
778
548
1,047
1,374
Deferred Taxes
1,664
1,379
568
154
642
Total Liabilities
37,618
40,020
20,888
21,792
15,309
Common Equity (Total)
67,959
75,988
72,127
77,424
83,863
Total Shareholders' Equity
67,959
75,988
72,127
77,424
83,863
Total Equity
67,959
75,988
72,127
77,424
83,863
Liabilities & Shareholders' Equity
105,576
116,008
93,014
99,216
99,172

About Estechpharma Co.

View Profile
Address
25 Barangongdan-ro
Hwaseong-si GY 18608
Korea, Republic Of
Employees -
Website http://www.estechpharma.com
Updated 09/14/2018
Estechpharma Co., Ltd. engages in the manufacture and supply of pharmaceutical ingredients and fine chemicals. Its products include treatment of alcoholism, anti-inflammatory, analgesics, muscle relaxant, antiseptic, antispasmodics, anti-cataracts, capillary protectant, unnatural amino acid, anti-hepatitis, anti-parkinsonian, antihistamine, nootropic and anti-diabetics. The company was founded on June 1, 1996 and is headquartered in Hwaseong-si, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.